MedStorm Innovation faces the challenges of pain management by offering a unique PainSensor for precise measurement of real-time pain assessment. The PainSensor measures pure changes in skin conductance, and is therefore not influenced by hemodynamic and respiratory instability. The technology can be used to tailor the need for analgesia and sedatives, to reduce side effects from over- and under sedation, as well as reducing the length of stay and costs for the hospitals. The PainSensor has various features and application areas for the hospitals and for home-treatment of patients (e.g. intensive care and palliative care). MedStorm Innovation is further developing other telemedicine, data storage and cloud-solutions, constantly aiming to improve patient care and caregiver satisfaction.
MedStorm offers a unique solution to improve the quality of pain management and daily workload in the wards. Pain is treated as the fifth vital sign, emphasizing the importance of high-quality pain management. The use of MedStorm’s PainSensor can, among others, tailor the need for analgesia, reduce side effects from over- and under sedation, as well as reducing the length of stay and costs for the hospitals. In addition, the PainSensor has applications for home-treatment of patients (e.g. intensive care and palliative care), with other telemedicine and cloud-storage solutions under development.
MedStorm’s real-time, IP protected PainSensor is based on skin conductance changes during anaesthesia, intensive care, postoperatively and in preterm infants. Additionally, the device has indices for assessing awakening, withdrawal symptoms, and the effect of regional nerve-block within seconds. The PainSensor is in the process of being CE certified.
MedStorm’s technology is based on 20 years of medical research, and there are more than 70 supportive validation studies and 3 theses. All studies show that the index increases during pain and nociceptive stimuli, and may predict painful events more sensitively and specifically than other available tools in all age groups. Moreover, the index decreases when analgesia is given. The index reacts within seconds, has low variation between and within individuals, and has higher accuracy to assess pain responses as compared to current methods. MedStorm PainSensor is unique in measuring pure skin-conductance signals, and is therefore not influenced by hemodynamic and respiratory instability.